Immunomodulation of activated hepatic stellate cells by mesenchymal stem cells
- 30 May 2007
- journal article
- Published by Elsevier
- Vol. 363 (2) , 247-252
- https://doi.org/10.1016/j.bbrc.2007.05.150
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Bone marrow-derived fibrocytes participate in pathogenesis of liver fibrosisJournal of Hepatology, 2006
- The role and regulation of hepatic stellate cell apoptosis in reversal of liver fibrosisApoptosis, 2005
- Matrix-mediated retention of adipogenic differentiation potential by human adult bone marrow-derived mesenchymal stem cells during ex vivo expansionBiomaterials, 2005
- Growth Inhibition and Apoptosis in Liver Myofibroblasts Promoted by Hepatocyte Growth Factor Leads to Resolution from Liver CirrhosisThe American Journal of Pathology, 2005
- Transplantation of Bone Marrow Cells Reduces Ccl4–Induced Liver Fibrosis in MiceHepatology, 2004
- Combinatorial signaling pathways determine fibroblast proliferation and myofibroblast differentiationThe FASEB Journal, 2004
- Transforming growth factor β and tumor necrosis factor α inhibit both apoptosis and proliferation of activated rat hepatic stellate cellsHepatology, 1999
- Interleukin–10 Expression and Function in Experimental Murine Liver Inflammation and FibrosisHepatology, 1998
- Primary Rat and Mouse Hepatic Stellate Cells Express the Macrophage Inhibitor Cytokine Interleukin–10 During the Course of Activation In VitroHepatology, 1998
- Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors.Journal of Clinical Investigation, 1998